Cargando…
Elabela, a Novel Peptide, Exerts Neuroprotective Effects Against Ischemic Stroke Through the APJ/miR-124-3p/CTDSP1/AKT Pathway
Elabela (ELA), which is the second endogenous peptide ligand of the apelin receptor (APJ) to be discovered, has been widely studied for potential use as a therapeutic peptide. However, its role in ischemic stroke (IS), which is a leading cause of disability and death worldwide and has limited therap...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10333378/ https://www.ncbi.nlm.nih.gov/pubmed/37106272 http://dx.doi.org/10.1007/s10571-023-01352-6 |
_version_ | 1785070640427958272 |
---|---|
author | Zhang, Kang-long Li, Shuang-mei Hou, Jing-yu Hong, Ying-hui Chen, Xu-xiang Zhou, Chang-qing Wu, Hao Zheng, Guang-hui Zeng, Chao-tao Wu, Hai-dong Fu, Jia-ying Wang, Tong |
author_facet | Zhang, Kang-long Li, Shuang-mei Hou, Jing-yu Hong, Ying-hui Chen, Xu-xiang Zhou, Chang-qing Wu, Hao Zheng, Guang-hui Zeng, Chao-tao Wu, Hai-dong Fu, Jia-ying Wang, Tong |
author_sort | Zhang, Kang-long |
collection | PubMed |
description | Elabela (ELA), which is the second endogenous peptide ligand of the apelin receptor (APJ) to be discovered, has been widely studied for potential use as a therapeutic peptide. However, its role in ischemic stroke (IS), which is a leading cause of disability and death worldwide and has limited therapeutic options, is uncertain. The aim of the present study was to investigate the beneficial effects of ELA on neuron survival after ischemia and the underlying molecular mechanisms. Primary cortical neurons were isolated from the cerebral cortex of pregnant C57BL/6J mice. Flow cytometry and immunofluorescence showed that ELA inhibited oxygen–glucose deprivation (OGD) -induced apoptosis and axonal damage in vitro. Additionally, analysis of the Gene Expression Omnibus database revealed that the expression of microRNA-124-3p (miR-124-3p) was decreased in blood samples from patients with IS, while the expression of C-terminal domain small phosphatase 1 (CTDSP1) was increased. These results indicated that miR-124-3p and CTDSP1 were related to ischemic stroke, and there might be a negative regulatory relationship between them. Then, we found that ELA significantly elevated miR-124-3p expression, suppressed CTDSP1 expression, and increased p-AKT expression by binding to the APJ receptor under OGD in vitro. A dual-luciferase reporter assay confirmed that CTDSP1 was a direct target of miR-124-3p. Furthermore, adenovirus-mediated overexpression of CTDSP1 exacerbated neuronal apoptosis and axonal damage and suppressed AKT phosphorylation, while treatment with ELA or miR-124-3p mimics reversed these effects. In conclusion, these results indicated that ELA could alleviate neuronal apoptosis and axonal damage by upregulating miR-124-3p and activating the CTDSP1/AKT signaling pathway. This study, for the first time, verified the protective effect of ELA against neuronal injury after ischemia and revealed the underlying mechanisms. We demonstrated the potential for the use of ELA as a therapeutic agent in the treatment of ischemic stroke. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10571-023-01352-6. |
format | Online Article Text |
id | pubmed-10333378 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-103333782023-07-12 Elabela, a Novel Peptide, Exerts Neuroprotective Effects Against Ischemic Stroke Through the APJ/miR-124-3p/CTDSP1/AKT Pathway Zhang, Kang-long Li, Shuang-mei Hou, Jing-yu Hong, Ying-hui Chen, Xu-xiang Zhou, Chang-qing Wu, Hao Zheng, Guang-hui Zeng, Chao-tao Wu, Hai-dong Fu, Jia-ying Wang, Tong Cell Mol Neurobiol Original Research Elabela (ELA), which is the second endogenous peptide ligand of the apelin receptor (APJ) to be discovered, has been widely studied for potential use as a therapeutic peptide. However, its role in ischemic stroke (IS), which is a leading cause of disability and death worldwide and has limited therapeutic options, is uncertain. The aim of the present study was to investigate the beneficial effects of ELA on neuron survival after ischemia and the underlying molecular mechanisms. Primary cortical neurons were isolated from the cerebral cortex of pregnant C57BL/6J mice. Flow cytometry and immunofluorescence showed that ELA inhibited oxygen–glucose deprivation (OGD) -induced apoptosis and axonal damage in vitro. Additionally, analysis of the Gene Expression Omnibus database revealed that the expression of microRNA-124-3p (miR-124-3p) was decreased in blood samples from patients with IS, while the expression of C-terminal domain small phosphatase 1 (CTDSP1) was increased. These results indicated that miR-124-3p and CTDSP1 were related to ischemic stroke, and there might be a negative regulatory relationship between them. Then, we found that ELA significantly elevated miR-124-3p expression, suppressed CTDSP1 expression, and increased p-AKT expression by binding to the APJ receptor under OGD in vitro. A dual-luciferase reporter assay confirmed that CTDSP1 was a direct target of miR-124-3p. Furthermore, adenovirus-mediated overexpression of CTDSP1 exacerbated neuronal apoptosis and axonal damage and suppressed AKT phosphorylation, while treatment with ELA or miR-124-3p mimics reversed these effects. In conclusion, these results indicated that ELA could alleviate neuronal apoptosis and axonal damage by upregulating miR-124-3p and activating the CTDSP1/AKT signaling pathway. This study, for the first time, verified the protective effect of ELA against neuronal injury after ischemia and revealed the underlying mechanisms. We demonstrated the potential for the use of ELA as a therapeutic agent in the treatment of ischemic stroke. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10571-023-01352-6. Springer US 2023-04-27 2023 /pmc/articles/PMC10333378/ /pubmed/37106272 http://dx.doi.org/10.1007/s10571-023-01352-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Research Zhang, Kang-long Li, Shuang-mei Hou, Jing-yu Hong, Ying-hui Chen, Xu-xiang Zhou, Chang-qing Wu, Hao Zheng, Guang-hui Zeng, Chao-tao Wu, Hai-dong Fu, Jia-ying Wang, Tong Elabela, a Novel Peptide, Exerts Neuroprotective Effects Against Ischemic Stroke Through the APJ/miR-124-3p/CTDSP1/AKT Pathway |
title | Elabela, a Novel Peptide, Exerts Neuroprotective Effects Against Ischemic Stroke Through the APJ/miR-124-3p/CTDSP1/AKT Pathway |
title_full | Elabela, a Novel Peptide, Exerts Neuroprotective Effects Against Ischemic Stroke Through the APJ/miR-124-3p/CTDSP1/AKT Pathway |
title_fullStr | Elabela, a Novel Peptide, Exerts Neuroprotective Effects Against Ischemic Stroke Through the APJ/miR-124-3p/CTDSP1/AKT Pathway |
title_full_unstemmed | Elabela, a Novel Peptide, Exerts Neuroprotective Effects Against Ischemic Stroke Through the APJ/miR-124-3p/CTDSP1/AKT Pathway |
title_short | Elabela, a Novel Peptide, Exerts Neuroprotective Effects Against Ischemic Stroke Through the APJ/miR-124-3p/CTDSP1/AKT Pathway |
title_sort | elabela, a novel peptide, exerts neuroprotective effects against ischemic stroke through the apj/mir-124-3p/ctdsp1/akt pathway |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10333378/ https://www.ncbi.nlm.nih.gov/pubmed/37106272 http://dx.doi.org/10.1007/s10571-023-01352-6 |
work_keys_str_mv | AT zhangkanglong elabelaanovelpeptideexertsneuroprotectiveeffectsagainstischemicstrokethroughtheapjmir1243pctdsp1aktpathway AT lishuangmei elabelaanovelpeptideexertsneuroprotectiveeffectsagainstischemicstrokethroughtheapjmir1243pctdsp1aktpathway AT houjingyu elabelaanovelpeptideexertsneuroprotectiveeffectsagainstischemicstrokethroughtheapjmir1243pctdsp1aktpathway AT hongyinghui elabelaanovelpeptideexertsneuroprotectiveeffectsagainstischemicstrokethroughtheapjmir1243pctdsp1aktpathway AT chenxuxiang elabelaanovelpeptideexertsneuroprotectiveeffectsagainstischemicstrokethroughtheapjmir1243pctdsp1aktpathway AT zhouchangqing elabelaanovelpeptideexertsneuroprotectiveeffectsagainstischemicstrokethroughtheapjmir1243pctdsp1aktpathway AT wuhao elabelaanovelpeptideexertsneuroprotectiveeffectsagainstischemicstrokethroughtheapjmir1243pctdsp1aktpathway AT zhengguanghui elabelaanovelpeptideexertsneuroprotectiveeffectsagainstischemicstrokethroughtheapjmir1243pctdsp1aktpathway AT zengchaotao elabelaanovelpeptideexertsneuroprotectiveeffectsagainstischemicstrokethroughtheapjmir1243pctdsp1aktpathway AT wuhaidong elabelaanovelpeptideexertsneuroprotectiveeffectsagainstischemicstrokethroughtheapjmir1243pctdsp1aktpathway AT fujiaying elabelaanovelpeptideexertsneuroprotectiveeffectsagainstischemicstrokethroughtheapjmir1243pctdsp1aktpathway AT wangtong elabelaanovelpeptideexertsneuroprotectiveeffectsagainstischemicstrokethroughtheapjmir1243pctdsp1aktpathway |